March 19, 2012
Article
Evidence-Based Oncology
Metabolomics, Proteomics, and Epigenetics
March 16, 2012
Article
Evidence-Based Oncology
Why Oncologists Must Tailor Clinical Features to Their Needs
March 16, 2012
Article
Evidence-Based Oncology
Promise and Pitfalls Along the Path to Personalized Care
March 16, 2012
Article
Evidence-Based Oncology
The Duke Cancer Institute
March 16, 2012
Article
Evidence-Based Oncology
To help oncology providers better understand drug mechanisms of action, and the economic implications of their use.
March 16, 2012
Article
Evidence-Based Oncology
Review of the most recent evidence-based literature discussing breast, colorectal, lung, and ovarian cancers, in addition to melanoma and multiple myeloma.
March 16, 2012
Article
Evidence-Based Oncology
How Much Do We Spend and How Can We Spend It Better?
March 12, 2012
Article
Evidence-Based Oncology
Insights Into Value-Based Insurance Design in Oncology
March 12, 2012
Article
Evidence-Based Oncology
Radical Changes in Payment Incentives and Elimination of Low-Value Care
March 12, 2012
Article
Evidence-Based Oncology
Health Plans Continue to Seek Methods to Curtail Cancer Costs
March 12, 2012
Article
Evidence-Based Oncology
Grim Reality Is a Bitter Pill to Swallow: Interview with Michael P. Link, MD, ASCO President
March 12, 2012
Article
Evidence-Based Oncology
The Challenges Facing Oncologists Are Formidable
March 12, 2012
Article
Evidence-Based Oncology
A New Era in Targeted Treatment Has Begun